# Breakthrough treatment for endometrial cancer

> New drug reduces cancer spread and death for women with advanced endometrial cancer.
- Title: Breakthrough treatment for endometrial cancer · New York Post
- Summary: New drug reduces cancer spread and death for women with advanced endometrial cancer. Sacituzumab tirumotecan (sac-TMT) lowers recurrence and death risk for…
- Keywords: endometrial cancer, sacituzumab tirumotecan, sac-tmt, trop-2, nyu langone health, perlmutter cancer center, phase 3 trial, recurrent endometrial cancer, news, entertainment, Breakthrough, treatment
- Source: New York Post — https://nypost.com/2026/10/26/health/breakthrough-in-fight-against-devastating-disease-that-kills-90k-a-year
- Published: 2026-10-26T14:50:02+00:00
- Read time: 1 min
- Topics: endometrial cancer, sacituzumab tirumotecan, sac-tmt, trop-2, nyu langone health, perlmutter cancer center, phase 3 trial, recurrent endometrial cancer, news, entertainment
## New treatment for endometrial cancer
Researchers from NYU Langone Health and Perlmutter Cancer Center found a drug that lowers cancer recurrence and death risk.
## Drug reduces cancer spread and death
The drug lowers recurrence risk by 41% and death risk by 32% for women with advanced endometrial cancer.
## Drug shows positive responses
35% of women treated with the drug showed tumor shrinkage, more than twice the rate for standard chemotherapy.
## Study principal investigator
Bhavana Pothuri says the drug is a new standard treatment for recurrent endometrial cancer.
## Drug targets cancer cells
The drug attaches to Trop-2 protein on endometrial cancer cells to deliver targeted treatment.
## Clinical guidelines to change
Pothuri recommends clinical guidelines for endometrial cancer will need to be updated to include the drug.
## Key takeaway

Sacituzumab tirumotecan (sac-TMT) lowers recurrence and death risk for endometrial cancer patients by 41% and 32% respectively.